Table 1. Overview of TFF interactions.
Interaction | Target location | Experimental approach | Note | Ref. | |
---|---|---|---|---|---|
TFF1 | GKN2 | AGS, HT-29, HGT-1 and NS-1 cells | Immunoprecipitation | Synergistic anti-proliferative and pro-apoptotic effects | [1, 10] |
MUC2 MUC5AC |
Stomach and duodenum | Yeast two-hybrid system | Interacts with VWFC1/VWFC2 domains. Demonstrated in vitro | [1, 7] | |
RF-LPS | Helicobacter pylori | SPR, coimmunofluoresence and incubation with tissue sections | Explains the bacteria tropism for colonising gastric tissue. Interacts with the carbohydrate moiety. | [15] | |
TFF2 | CXCR4 | Jurkat and AGS expressing CXCR4 cell lines | Ca2+mobilization | Activity at 500 nM | [4] |
PAR4 | HT-29 cells | Receptor knockdown by siRNA | Induced cell migration at 200 nM | [9] | |
DMBT1 | Porcine stomach membranes | Affinity chromatography | Putative receptor. No signalling upon binding was shown | [7] | |
β-integrin | Porcine stomach membranes | Affinity chromatography | Non-covalent interaction; potential/role in cell migration | [7] | |
MUC6 | Gastric mucus | MS identification & binding assay | Binds to GlcNAcα1→4Galβ1→R | [13, 14] | |
TFF3 | CXCR4 CXCR7 |
Ocular surface tissue | Computational docking and functional assays | Induced cell migration at 760 nM | [8] |
PAR2 | HT-29 cells | Immunoprecipitation, siRNA and functional assays | Downregulates IL-6 and IL-8 | [3] | |
FCGBP | Human colonic tissue | Purification of heteromer and identification by MS | TFF3-FCGBP considered reservoir. Lacks motogenic activity | [12] | |
DMBT1 | Bronchoalveolar lavage and colon | ELISA assay | Ca2+ dependent manner (typical of lectins) | [11] |
GKN2: gastrokine 2; MUC: mucin; VWFC: von Willebrand factor; RF-LPS: oligosaccharide portion of lipopolysaccharide; SPR: surface plasmon resonance; CXCR: C-X-C chemokine receptor; PAR: protease-activated receptors; DMBT1: deleted in malignant brain tumours 1; siRNA: small interfering RNA; FCGBP: IgG Fc binding protein; MS mass spectrometry.